EUVIMEDEUVIMED entdecken
Editorial

CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia

Didier Blaise

New England Journal of Medicine · 2024

DOI: 10.1056/nejme2403003 ↗

Kurz gefasst

Editorial in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Didier Blaise. Beteiligte Einrichtung: From the Department of Hematology, Transplant and Cellular Immunotherapy Program, Institut Paoli Calmettes, Management Sport Cancer laboratory, Aix-M…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Leukemia, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveLeukemiaReceptors, Chimeric AntigenTransplantation, HomologousHumansReceptors, Antigen, T-CellCombined Modality TherapyLeukemia, Myeloid, Acute

Substanzen

Receptors, Antigen, T-CellReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • From the Department of Hematology, Transplant and Cellular Immunotherapy Program, Institut Paoli Calmettes, Management Sport Cancer laboratory, Aix-Marseille University, Marseille, France.

Zitieren

APA

Blaise, D. (2024). CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia. New England Journal of Medicine. https://doi.org/10.1056/nejme2403003

Vancouver

Blaise D. CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia. New England Journal of Medicine. 2024. doi:10.1056/nejme2403003

BibTeX
@article{Blaise2024,
  author = {Blaise, Didier},
  title = {CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejme2403003}
}
Kostenlos starten →